4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-25-000129
Director acquired 12,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KANOVSKY STEPHEN M Director | 2025-06-01 | Option exercise | +12,254 | 52,344 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KANOVSKY STEPHEN M Director | 2025-06-01 | Option exercise · Restricted Stock Unit | −12,254 | 0 | D: show line 2 in the form | |||||
| KANOVSKY STEPHEN M Director | 2025-06-01 | Grant or award · Stock Option (Right to Buy) | +16,107 | 16,107 | D: show line 3 in the form | |||||
| KANOVSKY STEPHEN M Director | 2025-06-01 | Grant or award · Restricted Stock Unit | +23,077 | 23,077 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1748981284.xml…